Biolase Wins New FDA Waterlase Approval

SAN CLEMENTE, Calif., July 16 -- Biolase Technology Inc. has received further clearance from the US Food and Drug Administration to market its Waterlase dental laser for additional soft tissue procedures. These procedures include sulcular debridement and implant recovery.
Sulcular debridement is the removal of diseased tissue in the treatment of periodontal disease. Periodontal (gum) disease is the number-one oral health problem, with three out of four adults needing treatment for periodontal disease at some time in their lives, according to the American Dental Association.